CTA Editor Henry Kerali explores what impact blockchain could have on clinical research
- Virtual Clinical Trials: Are Site-less Trials the Future?
- Elucidating Opportunities for Cost Reduction of Clinical Trials Through Supply Management Optimization
- Industry Viewpoints: Digitizing Clinical Manufacturing
- Implementation of the 7T MRI in Clinical Trials
- Expert Insights: Serialization is a Necessary Step to Pharma Industry’s Adoption of Blockchain
Virtual Clinical Trials: Are Site-less Trials the Future?
CTA’s Anne-Marie Mongan unpacks the tangible benefits of going virtual
Elucidating Opportunities for Cost Reduction of Clinical Trials Through Supply Management Optimization
Anthony Zuccarello, Associate Director, IRT and Global Clinical Supply Strategy, Amicus Therapeutics, offers insight on how to create efficiencies within the clinical supply chain
Industry Viewpoints: Digitizing Clinical Manufacturing
Clive E. Badman, OBE, talks to CTA’s Charlie Abrines about the digitization of the clinical supply chain
The Million Dollar Question – How can Technology Improve Efficiency in the Clinical Supply Chain?
Rey Bacchus, Clinical Trial Supply Manager, Janssen Pharmaceutical R&D, examines what impact novel technology will have on supply chain processes
Expert Insights: Serialization is a Necessary Step to Pharma Industry’s Adoption of Blockchain
Peter Shapiro, Editor-In-Chief, PharmSource, guest writes for CTA and examines how serialization is key to a wider adoption of blockchain in pharma
Tech Giants Tackle Health Care: An Opportunity or Threat for the Pharmaceutical Industry?
CTA’s Anne-Marie Mongan explores whether the tech industry’s foray into health care is a benefit or hindrance to the industry
Social Media and Clinical Trials – Is the Hype all it’s made out to be?
CTA’s Charlie Abrines speaks to Adrian Orr, Director, Clinical Affairs, Anika Therapeutics, about the role social media can play in patient recruitment